M L Hancock

4.7k total citations · 1 hit paper
41 papers, 3.3k citations indexed

About

M L Hancock is a scholar working on Public Health, Environmental and Occupational Health, Hematology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, M L Hancock has authored 41 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Public Health, Environmental and Occupational Health, 14 papers in Hematology and 8 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in M L Hancock's work include Acute Lymphoblastic Leukemia research (17 papers), Acute Myeloid Leukemia Research (8 papers) and Childhood Cancer Survivors' Quality of Life (8 papers). M L Hancock is often cited by papers focused on Acute Lymphoblastic Leukemia research (17 papers), Acute Myeloid Leukemia Research (8 papers) and Childhood Cancer Survivors' Quality of Life (8 papers). M L Hancock collaborates with scholars based in United States, United Kingdom and Australia. M L Hancock's co-authors include Gaston K. Rivera, Ching‐Hon Pui, Susana C. Raimondi, John T. Sandlund, F G Behm, Mary V. Relling, William E. Evans, Jeffrey E. Rubnitz, R. C. Ribeiro and J R Downing and has published in prestigious journals such as The Lancet, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

M L Hancock

39 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mercaptopurine Therapy Intolerance and Heterozygosity at the Thiopurine S-Methyltransferase Gene Locus

1999 495 citations M L Hancock, Gaston K. Rivera et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M L Hancock United States	27	1.9k	1.4k	917	729	432	41	3.3k
Carmelo Rizzari Italy	34	2.1k 1.1×	1.6k 1.1×	1.4k 1.5×	851 1.2×	572 1.3×	140	3.9k
Nobuko Hijiya United States	33	1.6k 0.8×	1.3k 0.9×	1.1k 1.2×	742 1.0×	623 1.4×	116	3.3k
Virginie Gandemer France	31	1.2k 0.6×	1.0k 0.8×	818 0.9×	439 0.6×	607 1.4×	139	2.7k
Joseph Mirro United States	35	2.0k 1.1×	2.7k 2.0×	497 0.5×	1.2k 1.7×	822 1.9×	93	4.7k
Mats Heyman Sweden	39	2.6k 1.4×	1.3k 0.9×	1.9k 2.1×	1.3k 1.7×	984 2.3×	152	4.6k
Alan S. Gamis United States	41	1.7k 0.9×	3.1k 2.3×	696 0.8×	1.6k 2.2×	1.1k 2.5×	222	5.0k
Theresa Hahn United States	32	1.1k 0.6×	1.9k 1.4×	486 0.5×	366 0.5×	1.1k 2.4×	142	3.6k
Jesper Heldrup Sweden	27	1.1k 0.6×	979 0.7×	408 0.4×	655 0.9×	285 0.7×	70	2.2k
Denis R. Miller United States	30	720 0.4×	985 0.7×	654 0.7×	412 0.6×	296 0.7×	98	2.7k
C. Philip Steuber United States	23	896 0.5×	1.1k 0.8×	460 0.5×	377 0.5×	296 0.7×	63	2.0k

Countries citing papers authored by M L Hancock

Since Specialization

Citations

This map shows the geographic impact of M L Hancock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M L Hancock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M L Hancock more than expected).

Fields of papers citing papers by M L Hancock

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M L Hancock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M L Hancock. The network helps show where M L Hancock may publish in the future.

Co-authorship network of co-authors of M L Hancock

This figure shows the co-authorship network connecting the top 25 collaborators of M L Hancock. A scholar is included among the top collaborators of M L Hancock based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M L Hancock. M L Hancock is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Patil, Tejas, Danielle Smith, Paul A. Bunn, et al.. (2018). P1.01-78 The Incidence of Brain Metastases in ROS1-Rearranged Non-Small Cell Lung Cancer at Diagnosis and Following Progression on Crizotinib. Journal of Thoracic Oncology. 13(10). S492–S493.

Taylor, Renea A., et al.. (2012). Effect of enobosarm, a selective androgen receptor modulator (SARM), on physical function in middle aged and elderly cancer patients, with <5% or ≥5% weight loss. Journal of Geriatric Oncology. 3. S98–S99. 1 indexed citations

Steiner, M. S., et al.. (2010). Effect of GTx-024, a selective androgen receptor modulator (SARM), on stair climb performance and quality of life (QOL) in patients with cancer cachexia.. Journal of Clinical Oncology. 28(15_suppl). 9147–9147. 3 indexed citations

Williams, Natalie A., Gary L. Davis, M L Hancock, & Sean Phipps. (2009). Optimism and Pessimism in Children with Cancer and Healthy Children: Confirmatory Factor Analysis of the Youth Life Orientation Test and Relations with Health-Related Quality of Life. Journal of Pediatric Psychology. 35(6). 672–682. 34 indexed citations

Coustan‐Smith, Elaine, Amar Gajjar, Nobuko Hijiya, et al.. (2004). Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia after first relapse. Leukemia. 18(3). 499–504. 93 indexed citations

Dervieux, Thierry, M L Hancock, William E. Evans, C-H Pui, & M V Relling. (2002). Effect of methotrexate polyglutamates on thioguanine nucleotide concentrations during continuation therapy of acute lymphoblastic leukemia with mercaptopurine. Leukemia. 16(2). 209–212. 27 indexed citations

Maze, T H, et al.. (1998). ELECTRONIC SCREENING IN THE I-35 CORRIDOR. Transportation quarterly. 52(1). 2 indexed citations

Walter, Andrew W., M L Hancock, Ching‐Hon Pui, et al.. (1998). Secondary brain tumors in children treated for acute lymphoblastic leukemia at St Jude Children's Research Hospital.. Journal of Clinical Oncology. 16(12). 3761–3767. 187 indexed citations

Sandlund, J T, Robert A. Krance, Ching‐Hon Pui, et al.. (1997). XYY syndrome in children with acute lymphoblastic leukemia. Medical and Pediatric Oncology. 28(1). 6–8. 7 indexed citations

10.

Rubnitz, Jeffrey E., James R. Downing, C-H Pui, et al.. (1997). TEL gene rearrangement in acute lymphoblastic leukemia: a new genetic marker with prognostic significance.. Journal of Clinical Oncology. 15(3). 1150–1157. 145 indexed citations

11.

Hancock, M L, et al.. (1996). MULTI-STATE APPLICATIONS OF INTELLIGENT TRANSPORTATION SYSTEMS FOR COMMERCIAL VEHICLE OPERATION. Transportation quarterly. 50(1). 2 indexed citations

12.

Kumagai, M, Atsushi Manabe, Ching‐Hon Pui, et al.. (1996). Stroma-supported culture in childhood B-lineage acute lymphoblastic leukemia cells predicts treatment outcome.. Journal of Clinical Investigation. 97(3). 755–760. 102 indexed citations

13.

Pui, C-H, F G Behm, J R Downing, et al.. (1994). 11q23/MLL rearrangement confers a poor prognosis in infants with acute lymphoblastic leukemia.. Journal of Clinical Oncology. 12(5). 909–915. 155 indexed citations

14.

Rivera, Gaston K., C‐H Pui, Minnie Abromowitch, et al.. (1991). Improved outcome in childhood acute lymphoblastic leukaemia with reinforced early treatment and rotational combination chemotherapy. The Lancet. 337(8733). 61–66. 306 indexed citations

15.

Bowman, Laura C., M L Hancock, Victor M. Santana, et al.. (1991). Impact of intensified therapy on clinical outcome in infants and children with neuroblastoma: the St Jude Children's Research Hospital experience, 1962 to 1988.. Journal of Clinical Oncology. 9(9). 1599–1608. 60 indexed citations

16.

Thompson, Elizabeth, Judith A. Wilimas, Laura C. Bowman, et al.. (1990). Myeloid neoplasia in children treated for solid tumours. The Lancet. 336(8712). 417–421. 85 indexed citations

17.

Mirro, Joseph, B. N. Rao, Dennis C. Stokes, et al.. (1989). A prospective study of Hickman/Broviac catheters and implantable ports in pediatric oncology patients.. Journal of Clinical Oncology. 7(2). 214–222. 123 indexed citations

18.

Hayes, F. Ann, Elizabeth I. Thompson, William H. Meyer, et al.. (1989). Therapy for localized Ewing's sarcoma of bone.. Journal of Clinical Oncology. 7(2). 208–213. 134 indexed citations

19.

Christensen, Michael L., Gaston K. Rivera, W R Crom, M L Hancock, & W. Evans. (1988). Effect of hydration on methotrexate plasma concentrations in children with acute lymphocytic leukemia.. Journal of Clinical Oncology. 6(5). 797–801. 27 indexed citations

20.

Hobbs, J R, et al.. (1987). BENEFICIAL EFFECT OF PRE-TRANSPLANT SPLENECTOMY ON DISPLACEMENT BONE MARROW TRANSPLANTATION FOR GAUCHER'S SYNDROME. The Lancet. 329(8542). 1111–1115. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact